CTEPH

FDA

Dec 05, 2018

Breakthrough Device Designation granted to the AI Software for CTEPH

Interpreting the Growth and Major Developments in the Medical Device Contract Manufacturing Market

Articles

Jun 19, 2026

The Next Wave of Radioligand Therapies: 5 Candidates to Watch

Articles

Mar 20, 2026

SOTYKTU Expands Its Reach as Bristol Myers Squibb Lands Key Approval in Psoriatic Arthritis

Articles

Mar 13, 2026

Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI

Articles

Mar 06, 2026

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper